Intrinsic tumour suppression

被引:1022
作者
Lowe, SW
Cepero, E
Evan, G
机构
[1] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA
[2] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA
关键词
D O I
10.1038/nature03098
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mutations that drive uncontrolled cell-cycle progression are requisite events in tumorigenesis. But evolution has installed in the proliferative programmes of mammalian cells a variety of innate tumour-suppressive mechanisms that trigger apoptosis or senescence, should proliferation become aberrant. These contingent processes rely on a series of sensors and transducers that act in a coordinated network to target the machinery responsible for apoptosis and cell-cycle arrest at different points. Although oncogenic mutations that disable such networks can have profound and varied effects on tumour evolution, they may leave intact latent tumour-suppressive potential that can be harnessed therapeutically.
引用
收藏
页码:307 / 315
页数:9
相关论文
共 99 条
  • [1] ASKEW DS, 1991, ONCOGENE, V6, P1915
  • [2] Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics
    Aslanian, A
    Iaquinta, PJ
    Verona, R
    Lees, JA
    [J]. GENES & DEVELOPMENT, 2004, 18 (12) : 1413 - 1422
  • [3] Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2F1 loss
    Baudino, TA
    Maclean, KH
    Brennan, J
    Parganas, E
    Yang, CY
    Aslanian, A
    Lees, JA
    Sherr, CJ
    Roussel, MF
    Cleveland, JL
    [J]. MOLECULAR CELL, 2003, 11 (04) : 905 - 914
  • [4] Normal human fibroblasts are resistant to RAS-induced senescence
    Benanti, JA
    Galloway, DA
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (07) : 2842 - 2852
  • [5] p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis
    Bergamaschi, D
    Gasco, M
    Hiller, L
    Sullivan, A
    Syed, N
    Trigiante, G
    Yulug, I
    Merlano, M
    Numico, G
    Comino, A
    Attard, M
    Reelfs, O
    Gusterson, B
    Bell, AK
    Heath, V
    Tavassoli, M
    Farrell, PJ
    Smith, P
    Lu, X
    Crook, T
    [J]. CANCER CELL, 2003, 3 (04) : 387 - 402
  • [6] Novel cancer therapy by reactivation of the p53 apoptosis pathway
    Bykov, VJN
    Wiman, KG
    [J]. ANNALS OF MEDICINE, 2003, 35 (07) : 458 - 465
  • [7] Cellular senescence as a tumor-suppressor mechanism
    Campisi, J
    [J]. TRENDS IN CELL BIOLOGY, 2001, 11 (11) : S27 - S31
  • [8] Essential role for oncogenic Ras in tumour maintenance
    Chin, L
    Tam, A
    Pomerantz, J
    Wong, M
    Holash, J
    Bardeesy, N
    Shen, Q
    O'Hagan, R
    Pantginis, J
    Zhou, H
    Horner, JW
    Cordon-Cardo, C
    Yancopoulos, GD
    DePinho, RA
    [J]. NATURE, 1999, 400 (6743) : 468 - 472
  • [9] A 2ND SIGNAL SUPPLIED BY INSULIN-LIKE GROWTH-FACTOR-II IN ONCOGENE-INDUCED TUMORIGENESIS
    CHRISTOFORI, G
    NAIK, P
    HANAHAN, D
    [J]. NATURE, 1994, 369 (6479) : 414 - 418
  • [10] The DNA damage checkpoint in embryonic cell cycles is dependent on the DNA-to-cytoplasmic ratio
    Conn, CW
    Lewellyn, AL
    Maller, JL
    [J]. DEVELOPMENTAL CELL, 2004, 7 (02) : 275 - 281